November 28, 2018   INNOVATION

MedDay completes patient enrolment in Phase III trial

PARIS: MedDay Pharmaceuticals has completed patient enrolment in the SPI2 Phase III clinical trial evaluating…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In



Already a member? Log in here